メタ情報
| meta description平均長 | 166.5 |
|---|
| OGPありページ数 | 17 |
|---|
| Twitterカードありページ数 | 17 |
|---|
内部リンク分析（Internal）
| ユニーク内部リンク数 | 53 |
|---|
| ページあたり内部リンク平均 | 47.53 |
|---|
キーワード分析（KeywordMap）
ワードクラウド上位
| 語 | 重み |
|---|
| your | 1 |
| you | 0.752941 |
| personal | 0.741176 |
| Service | 0.458824 |
| data | 0.401606 |
| may | 0.381748 |
| information | 0.329412 |
| Phase | 0.255149 |
| use | 0.223287 |
| Privacy | 0.211765 |
| party | 0.211765 |
| legal | 0.211765 |
| such | 0.204389 |
| Policy | 0.2 |
| DATA | 0.188235 |
| processing | 0.188235 |
| third | 0.186616 |
| services | 0.176471 |
| YOUR | 0.176471 |
| PERSONAL | 0.176471 |
| not | 0.172867 |
| email | 0.168843 |
| our | 0.166376 |
| privacy | 0.164706 |
| purposes | 0.164706 |
| will | 0.159956 |
| Data | 0.142183 |
| any | 0.12965 |
| time | 0.129412 |
| applicable | 0.129412 |
| service | 0.129412 |
| clinical | 0.11884 |
| HOW | 0.117647 |
| business | 0.117647 |
| parties | 0.117647 |
| protection | 0.117647 |
| which | 0.116763 |
| other | 0.112439 |
| including | 0.108042 |
| out | 0.105882 |
| obefazimod | 0.10356 |
| week | 0.101633 |
| patients | 0.100354 |
| trial | 0.09948 |
| protected | 0.097751 |
| were | 0.096132 |
| Study | 0.094118 |
| Safety | 0.094118 |
| Enrollment | 0.094118 |
| remission | 0.094118 |
共起語上位
| 語1 | 語2 | スコア | 共起ページ数 |
|---|
| data | personal | 3.703678 | 243 |
| Policy | Privacy | 3.616986 | 64 |
| DATA | PERSONAL | 3.611484 | 58 |
| References | available | 3.495845 | 51 |
| PERSONAL | YOUR | 3.444897 | 53 |
| colitis | ulcerative | 3.40435 | 48 |
| email | protected | 3.226986 | 45 |
| President | Vice | 3.198824 | 33 |
| expression | miR | 3.161375 | 49 |
| daily | once | 3.085492 | 28 |
| Area | Economic | 3.085492 | 28 |
| party | third | 3.076917 | 55 |
| Crohn | disease | 3.008581 | 36 |
| Evaluate | Study | 3.001175 | 28 |
| Efficacy | Safety | 3.001175 | 28 |
| Colitis | Ulcerative | 3.001175 | 28 |
| Economic | European | 3.001175 | 28 |
| personal | your | 2.972437 | 171 |
| moderately | severely | 2.957061 | 24 |
| Anticipated | Milestones | 2.957061 | 24 |
| media | social | 2.957061 | 24 |
| Professional | advisors | 2.905087 | 22 |
| active | severely | 2.866629 | 24 |
| diseases | inflammatory | 2.847089 | 68 |
| available | upon | 2.843558 | 34 |
| References | upon | 2.822903 | 34 |
| DATA | YOUR | 2.816699 | 41 |
| action | mechanism | 2.719195 | 24 |
| 2b | Phase | 2.708395 | 60 |
| Authorities | others | 2.706941 | 20 |
| enrolled | patient | 2.699834 | 22 |
| Preclinical | Research | 2.669961 | 32 |
| homeostatic | levels | 2.657385 | 24 |
| Human | Resources | 2.624158 | 20 |
| resulted | stabilized | 2.618625 | 16 |
| bringing | chemokines | 2.618625 | 16 |
| Patient | Q2 | 2.618625 | 16 |
| Patient | enrollment | 2.618625 | 16 |
| Daily | Once | 2.618625 | 16 |
| Moderately | Severely | 2.618625 | 16 |
| Moderate | Severe | 2.618625 | 16 |
| online | services | 2.612722 | 28 |
| induction | week | 2.594088 | 45 |
| mechanism | novel | 2.558462 | 22 |
| POLICY | PRIVACY | 2.528312 | 17 |
| CAN | YOU | 2.528312 | 17 |
| Active | Ulcerative | 2.526246 | 20 |
| label | open | 2.526246 | 20 |
| chemokines | cytokines | 2.511331 | 16 |
| Q2 | track | 2.511331 | 16 |
被リンク情報
このデータの閲覧には会員登録が必要になります。会員登録